Increased risk of cervical cancer in high-risk families with and without mutations in the BRCA1 and BRCA2 genes

被引：0
|
作者：
Rhiem, K.
Fischer, C.
Bosse, K.
Wappenschmidt, B.
Schmutzler, R. K.
机构：
[1] Univ Cologne, Sch Med, Cologne, Germany
[2] Heidelberg Univ, Sch Med, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5588
引用
收藏
页数：1
相关论文
共 50 条
  • [41] No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families
    Nielsen, Henriette Roed
    Petersen, Janne
    Krogh, Lotte
    Nilbert, Mef
    Skytte, Anne-Bine
    FAMILIAL CANCER, 2016, 15 (04) : 523 - 528
  • [42] No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families
    Henriette Roed Nielsen
    Janne Petersen
    Lotte Krogh
    Mef Nilbert
    Anne-Bine Skytte
    Familial Cancer, 2016, 15 : 523 - 528
  • [43] BRCA1 and BRCA2 founder mutations are not associated with a high risk of colorectal cancer.
    Niell, BL
    Rennert, G
    Tomsho, LP
    Bonner, JD
    Gruber, SB
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 253 - 253
  • [44] Cancer with BRCA mutations in high-risk families
    Pisanelli, M. B.
    Panizza, E.
    Carbonardi, F.
    Iridile, C.
    Cavazzini, M. G.
    Carra, S.
    Cantore, M.
    Adami, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 14 - 14
  • [45] High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer
    Grzybowska, E
    Zientek, H
    Jasinska, A
    Rusin, M
    Kozlowski, P
    Sobczak, K
    Sikorska, A
    Kwiatkowska, E
    Gorniak , L
    Kalinowska, E
    Utracka-Hutka, B
    Wloch, J
    Chmielik, E
    Krzyzosiak, WJ
    HUMAN MUTATION, 2000, 16 (06) : 482 - 490
  • [46] Founder mutations in BRCA1 and BRCA2 genes
    Ferla, R.
    Calo, V.
    Cascio, S.
    Rinaldi, G.
    Badalamenti, G.
    Carreca, I.
    Surmacz, E.
    Coliucci, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 93 - 98
  • [47] Analysis of BRCA1 and BRCA2 mutations in high-risk patients from the Prague-area
    Pohlreich, P.
    Stribrna, J.
    Zikan, M.
    Kleibl, Z.
    Matous, B.
    Novotny, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 89 - 89
  • [48] Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2
    Saldia, Amethyst
    Olson, Sara H.
    Nunes, Pamela
    Liang, Xiaolin
    Samson, Marguerite L.
    Salo-Mullen, Erin
    Marcell, Vanessa
    Stadler, Zsofia K.
    Allen, Peter J.
    Offit, Kenneth
    Kurtz, Robert C.
    CANCER PREVENTION RESEARCH, 2019, 12 (09) : 599 - 607
  • [49] BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations
    Ahn, Sei Hyun
    Son, Byung Ho
    Yoon, Kyung-Sik
    Noh, Dong-Young
    Han, Wonshik
    Kim, Sung-Won
    Lee, Eun Sook
    Park, Hai-Lin
    Hong, Young Joon
    Choi, Jae Jin
    Moon, Seo Yun
    Kim, Mi Jeong
    Kim, Kye Hyun
    Kwak, Beom Seok
    Cho, Dae-Yeon
    CANCER LETTERS, 2007, 245 (1-2) : 90 - 95
  • [50] Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families
    Kauff, ND
    Perez-Segura, P
    Robson, ME
    Scheuer, L
    Siegel, B
    Schluger, A
    Rapaport, B
    Frank, TS
    Nafa, K
    Ellis, NA
    Parmigiani, G
    Offit, K
    JOURNAL OF MEDICAL GENETICS, 2002, 39 (08) : 611 - 614
12345